The added value of C-reactive protein measurement in diagnosing pneumonia in primary care:a meta-analysis of individual patient data

Autor: AW Graffelman, Geert-Jan Dinant, Arie Knuistingh Neven, Anette Holm, Alma C van de Pol, Joris A. H. de Groot, Ralph Gonzales, Hasse Melbye, Niek J. de Wit, Margaretha C. Minnaard, Saskia F. de Vries-van Vugt, Theo J M Verheij, Berna D L Broekhuizen, Alwin Schierenberg, Johann Steurer, Johannes B. Reitsma, Rogier M. Hopstaken, Timothy H. Rainer
Přispěvatelé: Family Medicine, RS: CAPHRI - R5 - Optimising Patient Care, University of Zurich, Minnaard, Margaretha C
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
medicine.medical_specialty
SYMPTOMS
ACCURACY
030106 microbiology
MEDLINE
610 Medicine & health
2700 General Medicine
Medical and Health Sciences
Procalcitonin
7.3 Management and decision making
03 medical and health sciences
0302 clinical medicine
Community-acquired pneumonia
Clinical Research
Internal medicine
Lower respiratory tract infection
General & Internal Medicine
INFECTION
medicine
Journal Article
030212 general & internal medicine
Intensive care medicine
PROCALCITONIN
Lung
screening and diagnosis
business.industry
Research
Area under the curve
LOWER RESPIRATORY-TRACT
COMMUNITY-ACQUIRED PNEUMONIA
SEARCH STRATEGIES
Pneumonia
General Medicine
PERFORMANCE
medicine.disease
Detection
Infectious Diseases
Meta-analysis
Cohort
Pneumonia & Influenza
Management of diseases and conditions
10029 Clinic and Policlinic for Internal Medicine
CLINICAL-PREDICTION
business
4.2 Evaluation of markers and technologies
ACUTE COUGH
Zdroj: Minnaard, M C, de Groot, J A H, Hopstaken, R M, Schierenberg, A, de Wit, N J, Reitsma, J B, Broekhuizen, B D L, van Vugt, S F, Knuistingh Neven, A, Graffelman, A W, Melbye, H, Rainer, T H, Steurer, J, Holm, A, Gonzales, R, Dinant, G-J, van de Pol, A C & Verheij, T J M 2017, ' The added value of C-reactive protein measurement in diagnosing pneumonia in primary care : a meta-analysis of individual patient data ', CMAJ : Canadian Medical Association Journal, vol. 189, no. 2, pp. E56-E63 . https://doi.org/10.1503/cmaj.151163
CMAJ, 189(2), E56-E63. Canadian Medical Association
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, vol 189, iss 2
Canadian Medical Association Journal, 189(2), E56. Canadian Medical Association
ISSN: 0820-3946
DOI: 10.1503/cmaj.151163
Popis: BACKGROUND: C-reactive protein (CRP) is increasingly being included in the diagnostic work-up for community-acquired pneumonia in primary care. Its added diagnostic value beyond signs and symptoms, however, remains unclear. We conducted a meta-analysis of individual patient data to quantify the added value of CRP measurement.METHODS: We included studies of the diagnostic accuracy of CRP in adult outpatients with suspected lower respiratory tract infection. We contacted authors of eligible studies for inclusion of data and for additional data as needed. The value of adding CRP measurement to a basic signs-and-symptoms prediction model was assessed. Outcome measures were improvement in discrimination between patients with and without pneumonia in primary care and improvement in risk classification, both within the individual studies and across studies.RESULTS: Authors of 8 eligible studies (n = 5308) provided their data sets. In all of the data sets, discrimination between patients with and without pneumonia improved after CRP measurement was added to the prediction model (extended model), with a mean improvement in the area under the curve of 0.075 (range 0.02-0.18). In a hypothetical cohort of 1000 patients, the proportion of patients without pneumonia correctly classified at low risk increased from 28% to 36% in the extended model, and the proportion with pneumonia correctly classified at high risk increased from 63% to 70%. The number of patients with pneumonia classified at low risk did not change (n = 4). Overall, the proportion of patients assigned to the intermediate-risk category decreased from 56% to 51%.INTERPRETATION: Adding CRP measurement to the diagnostic work-up for suspected pneumonia in primary care improved the discrimination and risk classification of patients. However, it still left a substantial group of patients classified at intermediate risk, in which clinical decision-making remains challenging.
Databáze: OpenAIRE